STI exposure or treatment follow-up

Template

Tap a choice or type a Repertoire Line to see how the note changes. Defaults are what the template inserts on its own.

Try a Repertoire Line

Practice wording only: leave out patient details. Nothing typed here is saved or sent.

Confidential interviewChoose any

ReviewedChoose any

VisitChoose oneFirst line

SymptomsChoose one

Gonorrhea and chlamydia testingChoose any

Trichomonas testingChoose any

HIV and syphilis testingChoose any

Other testingChoose any

TreatmentChoose one

PreventionChoose any

CounselingChoose any

Follow-upChoose one

Counseling paragraphChoose oneParagraph

Note when inserted as is

STI exposure or treatment follow-up
• Confidential time with the adolescent, with the limits of confidentiality reviewed
• Exposure, prior testing and treatment, symptoms, and partners reviewed
• Follow up as needed

Test results will be shared when they are back, and the office is available any time for questions. Return precautions given including pelvic or testicular pain, fever, vomiting, a new rash or sores, new symptoms, prolonged symptoms, worsening symptoms, and other concerns. Patient expressed understanding and agreement with plan. Answered all questions.

What the sources cover

Confidential time
Visit type (partner with chlamydia, gonorrhea, trichomoniasis, syphilis, HIV; 3-month retest; symptoms after treatment)
Testing by infection and exposure site
Presumptive treatment by exposure, with reasons (incl. Rocephin plus Doxycycline)
HIV PEP, PrEP, doxycycline PEP, vaccines
"Testing, treatment, partner management, and follow-up reviewed"

Return precautions in the template

pelvic or testicular painfevervomitinga new rash or sores

Sources

CDC Sexually Transmitted Infections Treatment Guidelines, 2021 (pages reviewed July 22, 2021; no later update notice)
HealthyChildren.org: Penile Adhesions and Skin Bridges
HealthyChildren.org: Varicocele
HealthyChildren.org: Delayed Puberty in Boys
International Evidence-based Guideline for PCOS (2023), adolescent recommendations. Peña AS et al., BMC Medicine 2025;23:151